Table of Content


Table of Contents 2
Tables 5
Charts 6
Octapharma AG - Key Company Facts 7
Octapharma AG - Company Description 8
Octapharma AG - Top Executives 9
Octapharma AG - Top Executives Biographies 10
Octapharma AG - Head Office & Locations 11
Head Office - Country 11
Key Subsidiaries 12
Octapharma AG - Products and Services 13
Products 13
Services 14
Octapharma AG - Historic Events 15
Octapharma AG - Corporate Strategy 17
Octapharma AG - Business Description 21
Hematology 21
Immunotherapy 22
Critical Care 22
Octapharma AG - ESG Spotlight 24
Environment 24
Social 25
Corporate Governance 26
Octapharma AG - SWOT Analysis 27
Overview 27
Strengths 30
Weaknesses 33
Opportunities 35
Threats 38
Competing Players 40
Snapshot of Competing Players 41
Abeona Therapeutics Inc. 41
Key Company Facts 41
Company Description 41
Almirall SA 43
Key Company Facts 43
Company Description 43
CSL Limited 45
Key Company Facts 45
Company Description 45
Grifols SA 47
Key Company Facts 47
Company Description 47
Liminal BioSciences Inc. 49
Key Company Facts 49
Company Description 49
Octapharma AG- Business Signals 50
Signal Sentiments Analytics 50
Signal Segments Analytics 51
Signal Segments by Sentiments Analytics 52
Signals by Sentiments Analytics 54
Octapharma AG - In the News 58
16-May-2024- Octapharma USA: Two decades of pioneering patient-centred care 58
07-May-2024- Octapharma makes a strong impression at the 2024 AAN Annual Meeting in Denver 58
09-Jan-2024- Octapharma Announces Availability of Balfaxar For Warfarin Reversal in Urgent Surgery and Invasive Procedures 59
07-Dec-2023- Octapharma USA: FDA Grants Expanded Approval to wilate as the First VWF Concentrate for Prophylaxis in All Types of VWD 61
07-Sep-2023- Heroes in the Fight: Octapharma To Be Honored for Myositis Research at TMA Annual Patient Conference 63
27-Jul-2023- Octapharma’s prothrombin complex concentrate, Balfaxar, receives FDA approval for warfarin reversal in urgent surgery and invasive procedures 65
21-Feb-2023- Octapharma USA Requests FDA Approval for wilate VWD Prophylaxis Supplement 67
Appendix 69
Definitions 69
SWOT Analysis 69
PESTLE Analysis 69
Value Chain Analysis 69
ESG Spotlight 69
Research Methodology 70
Disclaimer 71
Contact Us 71



List of Figures

Charts
Figure 1: Octapharma AG - SWOT Analysis 29
Figure 2: Competing Players - Abeona Therapeutics Inc. - Key Financials 42
Figure 3: Competing Players - Almirall SA - Key Financials 44
Figure 4: Competing Players - CSL Limited - Key Financials 46
Figure 5: Competing Players - Grifols SA - Key Financials 48
Figure 6: Octapharma AG - Business Signal Sentiments Analytics 50
Figure 7: Octapharma AG - Business Signal Segments Analytics 51
Figure 8: Octapharma AG - Business Signal Segments by Sentiments Analytics - Positive 52
Figure 9: Octapharma AG - Business Signal Segments by Sentiments Analytics - Negative 52
Figure 10: Octapharma AG - Business Signals by Sentiment Analytics - Positive 54
Figure 11: Octapharma AG - Business Signals by Sentiment Analytics - Negative 55

List of Tables

Tables
Table 1: Octapharma AG - Company Facts 7
Table 2: Octapharma AG - Top Executives 9
Table 3: Octapharma AG - Top Executives Biographies 10
Table 4: Octapharma AG - Subsidiaries 12
Table 5: Octapharma AG - Products 13
Table 6: Octapharma AG - Services 14
Table 7: Octapharma AG - Historic Events 15
Table 8: Octapharma AG -Competing Players 40
Table 9: Competing Players - Abeona Therapeutics Inc. - Key Company Facts 41
Table 10: Competing Players - Abeona Therapeutics Inc. - Key Financials 42
Table 11: Competing Players - Almirall SA - Key Company Facts 43
Table 12: Competing Players - Almirall SA - Key Financials 44
Table 13: Competing Players - CSL Limited - Key Company Facts 45
Table 14: Competing Players - CSL Limited - Key Financials 46
Table 15: Competing Players - Grifols SA - Key Company Facts 47
Table 16: Competing Players - Grifols SA - Key Financials 48
Table 17: Competing Players - Liminal BioSciences Inc. - Key Company Facts 49
Table 18: Octapharma AG - Business Signal Sentiments Analytics 50
Table 19: Octapharma AG - Business Signal Segments Analytics 51
Table 20: Octapharma AG - Business Signal Segments by Sentiments Analytics 53
Table 21: Octapharma AG - Business Signals by Sentiment Analytics 56
Table 22: Octapharma AG - Business Signal, Segment and Sentiment 57